Over half of treated patients with hypertension are not well controlled. However, little is known about physicians' prescribing behaviour for these patients. 
Introduction
Control of hypertension is not adequate even among treated patients. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Possible reasons include socioeconomic factors (such as lack of access to and the cost of care), biologic factors, professional shortcomings, 7 patient non-adherence, 7, 14 and lack of accepted consensus on best practice. 8 If physicians do not increase the medication for poorly controlled patients, control is unlikely to improve and patients are at risk of target organ damage over time. 1, [15] [16] [17] Little is known about physicians' behaviour in terms of prescribing for treated but poorly controlled patients. One study examined the relation between control of blood pressure and an increase in antihypertensive medication at each visit among treated Physicians increased medication in 28% of poorly controlled patients (95% confidence interval (CI), 17-41%), which was more than those in fair (12%, 95%CI 8-16%) or good control (7%, 95%CI 4 -12%). Multivariate logistic regression analysis showed that systolic and diastolic blood pressures were positively, and the number of kinds of antihypertensive medications and the age of the physician were negatively, associated with an increase in medication. In conclusion, primary care physicians did not increase antihypertensive medication adequately for patients with uncontrolled hypertension. Attempts to understand and to change physicians' prescription behaviour could reduce the burden of uncontrolled hypertension among treated hypertensive patients. male patients at five conveniently selected Veterans Affairs sites in the USA. 10 The authors concluded that many physicians did not adequately increase medication at visits in which blood pressure was high.
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We report a study among both male and female patients in a sample of randomly selected primary care clinics in Japan to clarify whether physicians increase antihypertensive medication adequately in patients with poorly controlled hypertension over a 1-year period and what characteristics are predictors of medication increase.
Patients and methods

Study design and setting
This retrospective cohort study by surveying medical records was conducted at primary care clinics in five medical service areas of 10 areas in Tochigi Prefecture, one of 47 administrative regions of Japan.
Study physicians
We randomly selected 20% (n = 79) of primary care clinics from 384 eligible clinics with specialty names that included internal medicine or cardiology. In Japan, general practice or family medicine is not yet an established specialty and the physicians who had been formerly specialists work as primary care physicians. Most of them were in private solo-practice. In September 1999, we telephoned briefly about the study to one physician who mainly managed the hypertensive patients at each clinic. Then we mailed the information about the study, a sample list and a data form, a questionnaire to examine the consent and characteristics of the physician, a stamped self-addressed return envelope, and a book coupon of 500 yen. We did not notify the physicians of any particular study hypothesis. We sent one reminder letter to the non-responders.
Study patients
Inclusion criteria of patients were those who had visited the clinics before April 1998 and were still visiting in October 1999 with hypertension. We did not set any exclusion criteria. We sent the participating physicians a form to list up to 23 consecutive eligible patients who visited during 4 weeks in October or November 1999. We randomly selected the starting day and time (am or pm) for listing from 1 week's office hours at each clinic, and faxed it to remind the physicians before the starting day.
Measures
The physicians could choose from two options about who would review medical records and fill-in the form, a researcher (YA) or the physicians themselves. The form was anonymous and to collect basic characteristics of patients, comorbidity related with hypertension, up to three recorded blood pressure measurements for each visit of the last five hypertension-related visits from 1 April to 31 August in 1998, and names and dosage of all antihypertensive medication in August in 1998 and 1999. Mean value of blood pressure was the average of all readings. Good control was defined as mean level of blood pressure of Ͻ140/90 mm Hg (both) and poor as blood pressure of у160/95 mm Hg (either). 1, 2, 15 The others were classified as fair.
Overall change in antihypertensive medication was the difference between August 1998 and August 1999. The change was classified in relation to dosage or number of kind of medications as: decrease, no change, or increase. The 'no change' category included occasions where there was no change in total number of kinds of medications but there was a change in kind of medication.
Sample size calculation and ethics
Based on a hypothesised medication change in 25% of all patients, a 5% width of 95% confidence interval (CI), an intracluster correlation of 0.01 which was slightly higher than a reported estimate of Kappa (0.0076), 18 and the average cluster size of 20, the number needed was 343 patients in 18 practices. An anticipated participation rate of 30% resulted in 60 practices being invited to participate. All participating physicians gave informed consent. This study was done as part of a Masters degree course of the University of Newcastle, Australia and approved by the Research Ethics committee of the University.
Statistical analysis
We 
Results
Participants
Four of the 79 eligible physicians refused to participate because of retirement (n = 3) or being too busy (n = 1) when we telephoned. Eighteen physicians did not respond, 28 chose not to participate, four dropped out, and 29 (37%) completed. One physician wanted us to visit his office to collect data. There were no statistically significant differences between the participating and non-participating physicians, sex (male/female: 27/2 and 27/2, respectively; P = 0.99 (Fisher's exact test)), age (30-39/40-49/50-59/60-69/70-(years): 1/15/7/1/5 and 0/10/6/5/8, respectively; P = 0.24) and area (Utsunomiya/Oyama/Tochigi/Haga/Kanuma: 13/5/4/5/2 and 15/5/5/4/1, respectively; P = 0.98). Additionally, participating physicians did not differ from all clinic physicians in Tochigi in sex (P = 0.42) and age (P = 0.12). 20 We obtained data of 547 patients, excluding 20 patients who did not meet inclusion criteria (Table 1 ). The median number of the patients per clinic was 20 (range, 4 to 24). These patients did not differ from the patients with hypertension in Tochigi in sex (female, 59%) and mean age (67.2 year), nor from those in Japan in sex (female, 61%) and mean age (67.5 year). 21 (1) a Any of the 11 conditions listed below.
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155 (28) Diabetes mellitus 79 (14) Angina 45 (8) Myocardial infarction 8 (2) Heart failure 12 (2) Transient ischaemic attack 6 (1) Cerebral infarction 34 (6) Cerebral haemorrhage 1 (0.2) Proteinuria 42 (8) Serum creatinine у2.0 mg/dl 4 (1) Fundal haemorrhage 4 (1) Peripheral artery disease 4
Office visit and blood pressure control
Blood pressure was measured a median of 1 (range, 1 to 3) time per visit and was measured at a median of 4 (range, 1 to 5) per five visits examined. The median of the mean intervals between visits in each clinic was 15 days (89% of the mean intervals were within 30 days). Mean (s.d.) blood pressure (systolic/diastolic) was 142 (12)/81 (9) mm Hg (n = 516). Percentages of the patients who were in good, fair, and poor control were 42%, 47%, and 11%, respectively, and 82% of patients had a blood pressure of Ͻ160/90 mm Hg (both).
Antihypertensive medication and change
Numbers (percentages) of patients who took zero, one, two, and three or more kinds of antihypertensive medication were, 35 (6%), 326 (60%), 151 (28%), and 35 (6%), respectively, in 1998, and 29 (5%), 318 (58%), 162 (30%) and 38 (7%), respectively, in 1999. Calcium channel antagonists were the most frequently prescribed class (n = 384 (70% of 547 patients) in 1998 and n = 394 (72%) in 1999), followed by angiotensin-converting enzyme inhibitors or angiotensin 2 receptor blockers (n = 129 (24%) and n = 140 (26%), beta-blockers or betaalpha-blockers (n = 81 (15%) and n = 85 (16%)), diuretics (n = 56 (15%) and n = 53 (10%)), alphablockers (n = 47 (9%) and n = 52 (10%)), and others (n = 30 (5%) and n = 30 (5%)). Overall, antihypertensive medication was decreased in 4% (95% CI, 3-6%) of patients, not changed in 84% (95% CI, 81-87%) of patients, and increased in 12% (95% CI, 9-15%) of patients. Medication was more likely to be increased in patients with a systolic blood pressure of у160 mm Hg, those with a diastolic blood pressure of у90
Journal of Human Hypertension mm Hg, and those in poor control (Table 2) . However, medication was not increased in 72% (95% CI, 59-83%) among poorly controlled patients. Reclassifying the 55 'no change' occasions where the total number of kinds of medication did not change but kind of medication changed to be included in the 'increase' category, produced similar results (numbers (%) of medication increase among patients with good, fair, and poor control were, respectively, 33/217 (15%), 52/241 (22%), and 23/58 (40%); P = 0.09 for comparison between good and fair, P Ͻ 0.001 for good and poor, and P = 0.007 for fair and poor, Fisher's exact test).
Factors associated with increase in antihypertensive medication
Univariate analysis showed six variables had Pvalues р0.25 among the 40 variables examined (Table 3) . Multivariate logistic regression analysis showed that systolic and diastolic blood pressure, the number of kinds of antihypertensive medications, and the age of the physician were significantly associated with an increase in medication (Table 3) .
Discussion
The main finding of this study is that although primary care physicians were more likely to increase antihypertensive medication in poorly controlled patients than the others, they did not increase medication in 72% of these poorly controlled patients over a 1-year period. These results are similar to that reported by Berlowitz and colleagues 10 who found that physicians increased medications at about a quarter of visits in which blood pressure was elevated (systolic у165 or diastolic у90 mm Hg) but at 5% of visits with blood pressure of Ͻ165/90 mm Hg. 10 Adamson and colleagues 11 reported that physicians took appropriate action (patient counselling and changing medication) in about a half of patients with uncontrolled diastolic blood pressure on two consecutive visits. These results indicate that physicians may not adequately change medication to get better control of hypertension, including increasing medication, for patients with uncontrolled hypertension.
Factors related to an increase of antihypertensive medication in one previous study were increased levels of both systolic and diastolic blood pressure, the pressure of coronary artery disease (among patients with a blood pressure of Ͻ165/90 mm Hg), a change in therapy at the preceding visit, and a scheduled visit. 10 Coronary artery disease was not related in our study probably because of the much lower prevalence of coronary artery disease in Japan. 22 The results of these studies suggest that the presence of other risk factors in hypertensive patients is not an important factor in whether physicians increase medication for treated patients. Our study showed that younger physicians were more likely to increase medication. It may be argued that this is because they knew the results of recent clinical trials for isolated systolic hypertension 23, 24 or recent guidelines 1 and therefore they were more aggressive to increase the medication.
It is interesting that antihypertensive medication was increased in 7% of patients with well-controlled hypertension. This might be because blood pressure rose after the former study period of prescription and before the latter (September 1998 to July 1999).
Our study has some limitations. First, reviewing the differences in medication over the 1-year period does not measure completely the physicians' prescribing behaviour. Change in type of medication was not classified as an increase or decrease if there was no change in total number of kinds of medications but there was a change in kind. This may have underestimated the appropriate prescribing behaviour. However, if we suppose that such changes were all classified as an increase, 60% of poorly controlled patients still did not have an increase in medication. Side effects leading to discontinuation of medication or a patient's refusal of a change in their prescription may be other reasons 317 for failure to change medication. Second, blood pressure was not measured by a standardised method. 25 However, physicians make decisions based on the recorded blood pressures and usually do not have access to standardised measurements. 26 Third, most physicians except one physicians abstracted data from medical records by themselves. This might introduce observer variation and bias toward better data, although each physician used a standardised format for data extraction. Even if our results are better than the truth, the percentage of increasing medication for uncontrolled hypertension is still low. Fourth, the participation rate of physicians was only 37%. This is understandable in the context of busy physicians but our generalisability is higher than in Adamson's study (10% participation rate), which used a similar sampling technique. 11 Our examination of the characteristics of participants and non-participants showed no systematic differences. Also, study physicians did not differ from those in Tochigi prefecture in sex and age, and study patients did not differ from those in Tochigi and in Japan in sex and age. Fifth, the patients may have had a better prognosis because they were survivors from the complication of hypertension and had adhered to follow-up visits for at least 1.5 years. It is unlikely that poorly controlled patients were selected more due to consecutive sampling, because the mean interval between hypertension-related visits did not differ among three groups of good, fair, and poor control. Sixth, the patients seem to visit for hypertension very frequently, but this practice pattern is typical in Japan. The reason is likely to be that the law limits the maximal date of prescription to 14 days for many drugs and 30 days even for drugs prescribed for chronic diseases, such as hypertension.
The results of this study warrant further studies to investigate whether attempts to understand and to change physicians' prescription behaviour could reduce the burden of uncontrolled hypertension among treated hypertensive patients.
In conclusion, primary care physicians in Japan did not adequately increase medication for uncontrolled hypertension. Fewer numbers of kinds of antihypertensive medications, younger age of the physician as well as higher systolic and diastolic blood pressure were predictors of an increase in medication.
